Evogenom Oy
PrivateLast Round
Early Funding
Oct 8, 2024
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Evogenom Oy operates in Healthcare & Life Sciences and is based in Jyväskylä. Its latest recorded funding round was an Early Funding round in October 2024.
Evogenom Oy is a biotechnology company that provides direct-to-consumer genetic testing services and personalized wellness recommendations through its mobile application and AI-powered coaching platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sports & Fitness, Personalization, D2C Brands, NLP & Conversational AI
Business Model
B2C
Customer Profile
Hardware + Subscription, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evogenom Oy Comparables
Compare Evogenom Oy with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| FitnessGenes | 82% | |
| Muhdo Health | 81% | |
| GenoPalate, Inc. | 81% |
For institutional investors. Book with your work email.
Evogenom Oy Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Evogenom Oy Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Trind VC | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors increased 47% MoM.
- Nov 12, 2025
Monthly visitors increased 135% MoM, reaching 4.4K.
For institutional investors. Book with your work email.
Evogenom Oy Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Evogenom Oy's valuation, stock price, and market status.
Is Evogenom Oy a public or private company?
Evogenom Oy is a private company.
What is the current stock price of Evogenom Oy?
Evogenom Oy is a private company, so its shares have no public market price. Caplight tracks Evogenom Oy's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Evogenom Oy worth (valuation)?
Valuation information for Evogenom Oy is not publicly available.
Can I buy Evogenom Oy stock?
Evogenom Oy shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Evogenom Oy's last funding round?
Evogenom Oy's most recent funding round was Early Funding on October 8, 2024.
Who are the main investors in Evogenom Oy?
Key investors in Evogenom Oy include Trind VC.
Will Evogenom Oy IPO soon?
No public IPO plans have been announced for Evogenom Oy.
How can I track Evogenom Oy secondary market activity?
Caplight tracks bids, offers, and trades in Evogenom Oy's shares on secondary markets.